Form 4 for ANIK Anika Therapeutics, Inc.
Accepted 2023-03-10 00:00:00 ET · period of report 2023-03-09 · accession 0001171843-23-001595 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-10 | 2023-03-09 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | F - Tax | $26.91 | -4,232 | 83.7K | -5% | -$113.9K |
| D | 2023-03-10 | 2023-03-09 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | +14.4K | 88.0K | +20% | $0 |
| D | 2023-03-10 | 2023-03-09 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | M - OptEx | $0.00 | -14.4K | 14.4K | -50% | $0 |
| DM | 2023-03-10 | 2023-03-09 | ANIK | Blanchard Cheryl R | Pres, CEO, Dir | A - Grant | $0.00 | +191.0K | 131.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-03-09 | F | D | 4,232 | $26.91 | 83,731 | D | — | — | (F3) Reflects an aggregate of 4,232 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on March 9, 2023. (F4) Reflects the closing price of ANIK common stock on March 9, 2023, the trading day on which the vesting of RSUs gave rise to tax withholding obligations. |
| 2 | Common | Common Stock | 2023-03-09 | M | A | 14,419 | $0.00 | 87,963 | D | — | — | (F1) Reflects the second vesting installment of Restricted Stock Units (RSUs) granted on March 9, 2021. (F2) Includes the following shares acquired under the Anika Therapeutics, Inc. Employee Stock Purchase Plan: 540 shares purchased on May 13, 2022 and 178 shares purchased on November 14, 2022. |
| 3 | Derivative | Restricted Stock Unit | 2023-03-09 | M | D | 14,419 | $0.00 | 14,420 | D | $0.00 · — to — | 14,419 Common Stock | (F9) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2022. |
| 4 | Derivative | Restricted Stock Unit | 2023-03-09 | A | A | 60,004 | $0.00 | 60,004 | D | $0.00 · — to — | 60,004 Common Stock | (F6) Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning March 9, 2024. |
| 5 | Derivative | Stock Option (Right to Buy) | 2023-03-09 | A | A | 130,998 | $0.00 | 130,998 | D | $29.60 · — to 2033-03-09 | 130,998 Common Stock | (F7) Represents a 10% premium above the closing price of Anika's common stock on the date of grant. (F8) The premium priced stock options vest in three equal annual installments beginning on March 9, 2024. |